PATRYS Ltd (PAB) - Net Assets
Based on the latest financial reports, PATRYS Ltd (PAB) has net assets worth AU$732.87K AUD (≈ $518.56K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$1.74 Million ≈ $1.23 Million USD) and total liabilities (AU$1.01 Million ≈ $711.96K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of PATRYS Ltd to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$732.87K |
| % of Total Assets | 42.14% |
| Annual Growth Rate | N/A |
| 5-Year Change | -93.91% |
| 10-Year Change | -79.86% |
| Growth Volatility | 64.51 |
PATRYS Ltd - Net Assets Trend (2007–2025)
This chart illustrates how PATRYS Ltd's net assets have evolved over time, based on quarterly financial data. Also explore PATRYS Ltd assets under control for the complete picture of this company's asset base.
Annual Net Assets for PATRYS Ltd (2007–2025)
The table below shows the annual net assets of PATRYS Ltd from 2007 to 2025. For live valuation and market cap data, see PATRYS Ltd stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$732.87K ≈ $518.56K |
-78.88% |
| 2024-06-30 | AU$3.47 Million ≈ $2.46 Million |
-49.25% |
| 2023-06-30 | AU$6.84 Million ≈ $4.84 Million |
-49.08% |
| 2022-06-30 | AU$13.43 Million ≈ $9.50 Million |
+11.50% |
| 2021-06-30 | AU$12.04 Million ≈ $8.52 Million |
+146.86% |
| 2020-06-30 | AU$4.88 Million ≈ $3.45 Million |
-33.15% |
| 2019-06-30 | AU$7.30 Million ≈ $5.16 Million |
+0.07% |
| 2018-06-30 | AU$7.29 Million ≈ $5.16 Million |
+173.80% |
| 2017-06-30 | AU$2.66 Million ≈ $1.88 Million |
-26.81% |
| 2016-06-30 | AU$3.64 Million ≈ $2.57 Million |
-8.36% |
| 2015-06-30 | AU$3.97 Million ≈ $2.81 Million |
-68.07% |
| 2014-06-30 | AU$12.43 Million ≈ $8.80 Million |
+15.42% |
| 2013-06-30 | AU$10.77 Million ≈ $7.62 Million |
-13.44% |
| 2012-06-30 | AU$12.45 Million ≈ $8.81 Million |
-7.57% |
| 2011-06-30 | AU$13.47 Million ≈ $9.53 Million |
-11.60% |
| 2010-06-30 | AU$15.23 Million ≈ $10.78 Million |
-14.02% |
| 2009-06-30 | AU$17.72 Million ≈ $12.54 Million |
-22.89% |
| 2008-06-30 | AU$22.98 Million ≈ $16.26 Million |
+1594.65% |
| 2007-06-30 | AU$-1.54 Million ≈ $-1.09 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to PATRYS Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7868707000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$86.01 Million | 11736.04% |
| Other Comprehensive Income | AU$925.47K | 126.28% |
| Other Components | AU$1.00 | 0.00% |
| Total Equity | AU$732.87K | 100.00% |
PATRYS Ltd Competitors by Market Cap
The table below lists competitors of PATRYS Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Augros Cosmetic Packaging SA
PA:AUGR
|
$6.99 Million |
|
Iceni Gold Ltd
AU:ICL
|
$7.00 Million |
|
Silver Elephant Mining Corp
TO:ELEF
|
$7.00 Million |
|
Greenlane Holdings Inc
NASDAQ:GNLN
|
$7.01 Million |
|
Perrot Duval Holding SA
SW:PEDU
|
$6.99 Million |
|
Khaitan (India) Limited
NSE:KHAITANLTD
|
$6.99 Million |
|
Kanger International Bhd
KLSE:0170
|
$6.98 Million |
|
Biomind Labs Inc
NEO:BMND
|
$6.98 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PATRYS Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,470,215 to 732,874, a change of -2,737,341 (-78.9%).
- Net loss of 3,013,303 reduced equity.
- Share repurchases of 32,401 reduced equity.
- New share issuances of 308,363 increased equity.
- Other comprehensive income decreased equity by 684,553.
- Other factors increased equity by 684,553.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-3.01 Million | -411.16% |
| Share Repurchases | AU$32.40K | -4.42% |
| Share Issuances | AU$308.36K | +42.08% |
| Other Comprehensive Income | AU$-684.55K | -93.41% |
| Other Changes | AU$684.55K | +93.41% |
| Total Change | AU$- | -78.88% |
Book Value vs Market Value Analysis
This analysis compares PATRYS Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 102.23x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 5.97x to 102.23x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-06-30 | AU$0.00 | AU$0.03 | x |
| 2008-06-30 | AU$0.13 | AU$0.03 | x |
| 2009-06-30 | AU$0.10 | AU$0.03 | x |
| 2010-06-30 | AU$0.07 | AU$0.03 | x |
| 2011-06-30 | AU$0.05 | AU$0.03 | x |
| 2012-06-30 | AU$0.04 | AU$0.03 | x |
| 2013-06-30 | AU$0.02 | AU$0.03 | x |
| 2014-06-30 | AU$0.02 | AU$0.03 | x |
| 2015-06-30 | AU$0.01 | AU$0.03 | x |
| 2016-06-30 | AU$0.00 | AU$0.03 | x |
| 2017-06-30 | AU$0.00 | AU$0.03 | x |
| 2018-06-30 | AU$0.01 | AU$0.03 | x |
| 2019-06-30 | AU$0.01 | AU$0.03 | x |
| 2020-06-30 | AU$0.00 | AU$0.03 | x |
| 2021-06-30 | AU$0.01 | AU$0.03 | x |
| 2022-06-30 | AU$0.01 | AU$0.03 | x |
| 2023-06-30 | AU$0.00 | AU$0.03 | x |
| 2024-06-30 | AU$0.00 | AU$0.03 | x |
| 2025-06-30 | AU$0.00 | AU$0.03 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently PATRYS Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -411.16%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -363.69%
- • Asset Turnover: 0.48x
- • Equity Multiplier: 2.37x
- Recent ROE (-411.16%) is below the historical average (-77.64%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | -31.88% | -658.60% | 0.05x | 1.04x | AU$-9.62 Million |
| 2009 | -48.89% | -231923.40% | 0.00x | 1.08x | AU$-10.43 Million |
| 2010 | -49.47% | -161906.38% | 0.00x | 1.07x | AU$-9.06 Million |
| 2011 | -55.12% | -97666.40% | 0.00x | 1.10x | AU$-8.77 Million |
| 2012 | -41.05% | -105316.24% | 0.00x | 1.07x | AU$-6.35 Million |
| 2013 | -32.76% | -133526.11% | 0.00x | 1.10x | AU$-4.61 Million |
| 2014 | -58.62% | -959.49% | 0.05x | 1.19x | AU$-8.53 Million |
| 2015 | -213.34% | -380.78% | 0.47x | 1.20x | AU$-8.87 Million |
| 2016 | -29.70% | -393.06% | 0.06x | 1.17x | AU$-1.44 Million |
| 2017 | -39.72% | -1986.14% | 0.02x | 1.19x | AU$-1.32 Million |
| 2018 | -34.25% | -479.76% | 0.07x | 1.09x | AU$-3.23 Million |
| 2019 | -5.64% | -48.71% | 0.11x | 1.09x | AU$-1.14 Million |
| 2020 | -56.35% | -9994.69% | 0.01x | 1.10x | AU$-3.24 Million |
| 2021 | -33.74% | -14774.25% | 0.00x | 1.07x | AU$-5.27 Million |
| 2022 | -50.50% | -24655.87% | 0.00x | 1.04x | AU$-8.12 Million |
| 2023 | -103.28% | -247.61% | 0.38x | 1.10x | AU$-7.75 Million |
| 2024 | -101.99% | -253.85% | 0.34x | 1.20x | AU$-3.89 Million |
| 2025 | -411.16% | -363.69% | 0.48x | 2.37x | AU$-3.09 Million |
Industry Comparison
This section compares PATRYS Ltd's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PATRYS Ltd (PAB) | AU$732.87K | -31.88% | 1.37x | $6.99 Million |
| Ordinary Fully Paid Deferred Settlement (88EDA) | $131.68 Million | -53.71% | 0.01x | $18.83 Million |
| Ordinary Fully Paid Deferred Settlement (BCNDA) | $62.29 Million | 8.39% | 0.41x | $14.69K |
| Perpetual Credit Income Trust (PCI) | $445.48 Million | 7.78% | 0.02x | $314.92 Million |
| Regal Investment Fund (RF1) | $342.96 Million | 50.99% | 1.48x | $484.25 Million |
| Regal Partners Global Investments Limited (RG1) | $643.12 Million | 9.97% | 0.34x | $15.74K |
| Rivco Australia Ltd (RIV) | $192.59 Million | 3.29% | 0.69x | $9.79K |
| Touch Ventures Ltd (TVL) | $216.00K | -1676.39% | 8.01x | $35.33 Million |
| Vgi Partners Global Investments Ltd (VG1) | $983.93 Million | 15.64% | 0.70x | $716.93 Million |
| Victory Metals Ltd (VTM) | $10.49 Million | -18.21% | 0.05x | $17.50 Million |
About PATRYS Ltd
Patrys Limited, together with its subsidiaries, develops antibody technologies for the treatment of cancer and NETosis-driven inflammatory diseases. It develops PAT-DX1, a small antibody fragment derived from a humanized version of the binding domain from the original mouse deoxymab antibody 3E10; and PAT-DX3 for treating primary and secondary brain cancers, and metastases that are associated wit… Read more